Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$38.2K
6 trades · 3 insiders
Net · 90d
$-38.2K
Insiders on file
46
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Ory Daniel Scott | EVP, Chief Medical Officer | 2 | $0 | $0 | 2026-09-08 |
| Parison Amy | SVP, Chief Financial Officer | 12 | $0 | $13.2K | 2026-09-03 |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | 20 | $0 | $120.9K | 2026-09-03 |
| O'Neill Gilmore Neil | CEO, Director | 24 | $0 | $1.04M | 2026-09-03 |
| Ellinor Patrick Thomas II | Director | 2 | $0 | $0 | 2026-08-06 |
| Levy Elliott M. | Director | 4 | $0 | $0 | 2026-06-17 |
| Scadden David | Director | 8 | $0 | $0 | 2026-06-17 |
| Connaughton Bernadette | Director | 6 | $0 | $0 | 2026-06-17 |
| Hopfield Jessica | Director | 13 | $1.01M | $0 | 2026-06-17 |
| Hirsch Andrew | Director | 10 | $0 | $0 | 2026-06-17 |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | 9 | $0 | $132.3K | 2025-03-08 |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | 14 | $0 | $269.7K | 2024-12-03 |
| Chatterjee Meeta | Director | 5 | $0 | $0 | 2024-05-30 |
| Reeve Emma | Director | 4 | $0 | $0 | 2024-05-30 |
| Vaishnaw Akshay | Director | 9 | $0 | $0 | 2024-05-30 |
| Eaton Bruce | EVP, Chief Business Officer | 28 | $0 | $154.8K | 2023-12-05 |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | 25 | $0 | $545.1K | 2023-05-11 |
| Shearman Mark S | EVP, Chief Scientific Officer | 7 | $0 | $78.7K | 2023-02-13 |
| MULLEN JAMES C | Director | 12 | $1.54M | $1.02M | 2022-04-14 |
| Michaels Lisa Anne | EVP/Chief Medical Officer | 4 | $0 | $60.1K | 2021-12-22 |
| Collins Cynthia | Interim CEO | 13 | $0 | $290.7K | 2021-02-09 |
| Albright Charles | EVP/Chief Scientific Officer | 40 | $0 | $3.69M | 2020-12-15 |
| Abrams Judith R | Chief Medical Officer | 2 | $0 | $0 | 2019-10-28 |
| Myer Vickesh | Chief Technology Officer | 68 | $0 | $2.38M | 2019-03-18 |
| Hack Andrew A. F. | Chief Financial Officer | 77 | $0 | $4.67M | 2019-02-04 |
| Bosley Katrine | President and CEO | 56 | $0 | $7.27M | 2019-01-08 |
| Nikolic Boris | Director | 5 | $492.4K | $0 | 2018-06-15 |
| Cox Gerald Frank | Chief Medical Officer | 3 | $56.6K | $0 | 2018-02-07 |
| Cole Douglas G. | Director | 3 | $0 | $0 | 2017-08-17 |
| Bitterman Kevin | Director, 10% Owner | 18 | $0 | $31.19M | 2017-06-15 |
| Borisy Alexis | Director | 5 | $0 | $0 | 2017-06-15 |
| MENDLEIN JOHN | Director | 2 | $0 | $0 | 2017-06-15 |
| Glucksmann Alexandra | Chief Operating Officer | 10 | $0 | $169.9K | 2017-03-15 |
| Polaris Venture Partners VI, L.P. | 10% Owner | 3 | $0 | $3.24M | 2016-12-07 |
| Polaris Venture Partners Founders' Fund VI, L.P. | 10% Owner | 11 | $0 | $10.24M | 2016-11-23 |
| Polaris Venture Management Co. VI, L.L.C. | 10% Owner | 2 | $0 | $704.7K | 2016-11-22 |
| STARR KEVIN P | 10% Owner | 5 | $0 | $93.7K | 2016-09-06 |
| Third Rock Ventures GP III, L.P. | 10% Owner | 1 | $0 | $0 | 2016-08-16 |
| Flagship Ventures Fund IV, L.P. | 10% Owner | 3 | $0 | $0 | 2016-08-11 |
| bng0, LLC | 10% Owner | 2 | $0 | $0 | 2016-02-08 |
| Ott David C. | 10% Owner | 11 | $0 | $0 | 2016-02-08 |
| Viking Long Fund GP LLC | Other | 11 | $0 | $0 | 2016-02-08 |
| Deerfield Mgmt III, L.P. | 10% Owner | 5 | $1.60M | $0 | 2016-02-08 |
| Viking Global Equities II LP | 10% Owner | 11 | $0 | $0 | 2016-02-08 |
| AFEYAN NOUBAR | 10% Owner | 12 | $0 | $0 | 2016-02-08 |
| HALVORSEN OLE ANDREAS | Other | 11 | $0 | $0 | 2016-02-08 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Ory Daniel Scott | EVP, Chief Medical Officer | A Award deriv | 2026-09-08 | 2026-09-09 | 950,000 | — | $0 | 950,000 | SEC↗ |
| Ory Daniel Scott | EVP, Chief Medical Officer | A Award deriv | 2026-09-08 | 2026-09-09 | 950,000 | — | $0 | 950,000 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2026-09-03 | 2026-09-04 | 5,124 | $3.04 | $15.6K | 243,189 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | S Sale | 2026-09-03 | 2026-09-04 | 453 | $3.04 | $1.4K | 13,839 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2026-09-03 | 2026-09-04 | 709 | $3.04 | $2.2K | 61,660 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | S Sale | 2026-09-03 | 2026-09-04 | 453 | $3.04 | $1.4K | 13,839 | SEC↗ |
| O'Neill Gilmore Neil | CEO, Director | S Sale | 2026-09-03 | 2026-09-04 | 5,124 | $3.04 | $15.6K | 243,189 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2026-09-03 | 2026-09-04 | 709 | $3.04 | $2.2K | 61,660 | SEC↗ |
| Ellinor Patrick Thomas II | Director | A Award deriv | 2026-08-06 | 2026-08-07 | 103,400 | — | $0 | 103,400 | SEC↗ |
| Ellinor Patrick Thomas II | Director | A Award deriv | 2026-08-06 | 2026-08-07 | 103,400 | — | $0 | 103,400 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | S Sale | 2026-08-03 | 2026-08-05 | 678 | $2.58 | $1.7K | 14,292 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | S Sale | 2026-08-03 | 2026-08-05 | 678 | $2.58 | $1.7K | 14,292 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2026-07-28 | 2026-07-29 | 4,928 | $2.67 | $13.2K | 62,369 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2026-07-28 | 2026-07-29 | 4,928 | $2.67 | $13.2K | 62,369 | SEC↗ |
| Levy Elliott M. | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 51,700 | — | $0 | 51,700 | SEC↗ |
| Scadden David | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 51,700 | — | $0 | 51,700 | SEC↗ |
| Hirsch Andrew | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 51,700 | — | $0 | 51,700 | SEC↗ |
| Hopfield Jessica | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 51,700 | — | $0 | 51,700 | SEC↗ |
| Connaughton Bernadette | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 51,700 | — | $0 | 51,700 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2026-06-03 | 2026-06-05 | 731 | $2.70 | $2.0K | 67,297 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2026-06-03 | 2026-06-05 | 15,380 | $2.70 | $41.5K | 248,313 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | S Sale | 2026-06-03 | 2026-06-05 | 464 | $2.70 | $1.3K | 14,970 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | A Award deriv | 2026-03-12 | 2026-03-16 | 292,856 | — | $0 | 292,856 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | A Award deriv | 2026-03-12 | 2026-03-16 | 292,856 | — | $0 | 292,856 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award deriv | 2026-03-12 | 2026-03-16 | 1,015,200 | — | $0 | 1,015,200 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2026-03-03 | 2026-03-04 | 749 | $2.02 | $1.5K | 68,028 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | S Sale | 2026-03-03 | 2026-03-04 | 474 | $2.02 | $957 | 15,434 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2026-03-03 | 2026-03-04 | 5,394 | $2.02 | $10.9K | 263,693 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | S Sale | 2025-12-03 | 2025-12-04 | 461 | $2.15 | $991 | 15,908 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2025-12-03 | 2025-12-04 | 5,603 | $2.15 | $12.0K | 269,087 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2025-12-03 | 2025-12-04 | 713 | $2.15 | $1.5K | 68,777 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2025-09-03 | 2025-09-04 | 5,592 | $2.60 | $14.5K | 274,690 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | S Sale | 2025-09-03 | 2025-09-04 | 458 | $2.60 | $1.2K | 16,369 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2025-09-03 | 2025-09-04 | 710 | $2.60 | $1.8K | 69,490 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | S Sale | 2025-08-07 | 2025-08-08 | 679 | $2.58 | $1.8K | 16,827 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2025-07-31 | 2025-08-04 | 5,121 | $2.49 | $12.8K | 64,398 | SEC↗ |
| Hirsch Andrew | Director | A Award deriv | 2025-06-06 | 2025-06-10 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Connaughton Bernadette | Director | A Award deriv | 2025-06-06 | 2025-06-10 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Levy Elliott M. | Director | A Award deriv | 2025-06-06 | 2025-06-10 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Scadden David | Director | A Award deriv | 2025-06-06 | 2025-06-10 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Hopfield Jessica | Director | A Award deriv | 2025-06-06 | 2025-06-10 | 37,500 | — | $0 | 37,500 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2025-06-03 | 2025-06-04 | 15,192 | $1.72 | $26.1K | 280,282 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2025-06-03 | 2025-06-04 | 726 | $1.72 | $1.2K | 69,519 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | S Sale | 2025-06-03 | 2025-06-04 | 446 | $1.72 | $767 | 17,506 | SEC↗ |
| Parison Amy | SVP, Chief Financial Officer | A Award deriv | 2025-04-08 | 2025-04-08 | 34,672 | — | $0 | 34,672 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | A Award deriv | 2025-03-08 | 2025-03-27 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | A Award deriv | 2025-03-08 | 2025-03-27 | 275,100 | — | $0 | 275,100 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award deriv | 2025-03-08 | 2025-03-27 | 828,000 | — | $0 | 828,000 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award deriv | 2025-03-08 | 2025-03-27 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A Award deriv | 2025-03-08 | 2025-03-27 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A Award deriv | 2025-03-08 | 2025-03-27 | 275,100 | — | $0 | 275,100 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2025-03-04 | 2025-03-05 | 2,891 | $1.71 | $4.9K | 70,245 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2025-03-04 | 2025-03-05 | 16,632 | $1.71 | $28.4K | 295,474 | SEC↗ |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | S Sale | 2025-03-04 | 2025-03-05 | 4,109 | $1.71 | $7.0K | 112,720 | SEC↗ |
| Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S Sale | 2024-12-03 | 2024-12-05 | 541 | $2.08 | $1.1K | 133,354 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2024-12-03 | 2024-12-05 | 1,618 | $2.08 | $3.4K | 312,106 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2024-09-04 | 2024-09-06 | 1,555 | $3.42 | $5.3K | 313,724 | SEC↗ |
| Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S Sale | 2024-09-04 | 2024-09-06 | 518 | $3.42 | $1.8K | 133,895 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2024-07-25 | 2024-07-26 | 11,886 | $5.42 | $64.4K | 73,136 | SEC↗ |
| Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S Sale | 2024-07-19 | 2024-07-22 | 6,619 | $5.21 | $34.5K | 134,413 | SEC↗ |
| Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S Sale | 2024-06-04 | 2024-06-06 | 511 | $5.50 | $2.8K | 141,032 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2024-06-04 | 2024-06-06 | 12,191 | $5.50 | $67.1K | 315,279 | SEC↗ |
| Vaishnaw Akshay | Director | A Award deriv | 2024-05-30 | 2024-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Connaughton Bernadette | Director | A Award deriv | 2024-05-30 | 2024-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Levy Elliott M. | Director | A Award deriv | 2024-05-30 | 2024-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Reeve Emma | Director | A Award deriv | 2024-05-30 | 2024-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hirsch Andrew | Director | A Award deriv | 2024-05-30 | 2024-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Chatterjee Meeta | Director | A Award deriv | 2024-05-30 | 2024-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hopfield Jessica | Director | A Award deriv | 2024-05-30 | 2024-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Scadden David | Director | A Award deriv | 2024-05-30 | 2024-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | S Sale | 2024-05-20 | 2024-05-22 | 22,337 | $5.61 | $125.3K | 116,829 | SEC↗ |
| Hopfield Jessica | Director | P Buy | 2024-05-13 | 2024-05-14 | 45,000 | $5.64 | $253.8K | 67,700 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2024-03-05 | 2024-03-05 | 77,824 | $9.42 | $733.1K | 327,470 | SEC↗ |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | S Sale | 2024-03-04 | 2024-03-05 | 20,327 | $9.42 | $191.5K | 141,543 | SEC↗ |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A Award deriv | 2024-03-02 | 2024-03-05 | 152,800 | — | $0 | 152,800 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award deriv | 2024-03-02 | 2024-03-05 | 392,100 | — | $0 | 392,100 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | A Award deriv | 2024-03-02 | 2024-03-05 | 74,400 | — | $0 | 74,400 | SEC↗ |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A Award deriv | 2024-03-02 | 2024-03-05 | 106,000 | — | $0 | 106,000 | SEC↗ |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A Award | 2024-03-02 | 2024-03-05 | 19,458 | — | $0 | 142,413 | SEC↗ |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A Award | 2024-03-02 | 2024-03-05 | 19,457 | — | $0 | 161,870 | SEC↗ |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A Award | 2024-03-02 | 2024-03-05 | 50,900 | — | $0 | 122,955 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award | 2024-03-02 | 2024-03-05 | 130,700 | — | $0 | 260,869 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award | 2024-03-02 | 2024-03-05 | 72,213 | — | $0 | 333,082 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award | 2024-03-02 | 2024-03-05 | 72,212 | — | $0 | 405,294 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | A Award | 2024-03-02 | 2024-03-05 | 15,055 | — | $0 | 85,022 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | A Award | 2024-03-02 | 2024-03-05 | 24,800 | — | $0 | 69,967 | SEC↗ |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A Award | 2024-03-02 | 2024-03-05 | 25,966 | — | $0 | 139,166 | SEC↗ |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A Award | 2024-03-02 | 2024-03-05 | 35,300 | — | $0 | 113,200 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-12-05 | 2023-12-07 | 103 | $10.90 | $1.1K | 74,791 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-11-14 | 2023-11-16 | 695 | $8.21 | $5.7K | 74,894 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-11-07 | 2023-11-09 | 139 | $8.40 | $1.2K | 75,589 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-09-06 | 2023-09-07 | 103 | $8.82 | $908 | 75,728 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-08-11 | 2023-08-15 | 702 | $8.59 | $6.0K | 75,831 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-08-08 | 2023-08-10 | 141 | $8.39 | $1.2K | 76,533 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | A Award deriv | 2023-07-24 | 2023-07-25 | 135,500 | — | $0 | 135,500 | SEC↗ |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICE | A Award | 2023-07-24 | 2023-07-25 | 45,167 | — | $0 | 45,167 | SEC↗ |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | S Sale | 2023-07-19 | 2023-07-21 | 4,317 | $8.80 | $38.0K | 72,055 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-06-05 | 2023-06-07 | 105 | $9.50 | $998 | 76,674 | SEC↗ |
| O'Neill Gilmore Neil | CEO | S Sale | 2023-06-05 | 2023-06-07 | 6,486 | $9.50 | $61.6K | 130,169 | SEC↗ |
| Chatterjee Meeta | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hirsch Andrew | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hopfield Jessica | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Scadden David | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Vaishnaw Akshay | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Connaughton Bernadette | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Reeve Emma | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A Award deriv | 2023-05-17 | 2023-05-18 | 155,800 | — | $0 | 155,800 | SEC↗ |
| Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A Award | 2023-05-17 | 2023-05-18 | 77,900 | — | $0 | 77,900 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-05-11 | 2023-05-15 | 668 | $9.87 | $6.6K | 76,779 | SEC↗ |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S Sale | 2023-05-11 | 2023-05-15 | 949 | $9.87 | $9.4K | 106,610 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-05-09 | 2023-05-11 | 135 | $9.51 | $1.3K | 77,447 | SEC↗ |
| Levy Elliott M. | Director | A Award deriv | 2023-04-11 | 2023-04-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-03-03 | 2023-03-06 | 101 | $8.89 | $898 | 77,582 | SEC↗ |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S Sale | 2023-03-03 | 2023-03-06 | 184 | $8.89 | $1.6K | 107,559 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | A Award deriv | 2023-03-02 | 2023-03-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award deriv | 2023-03-02 | 2023-03-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A Award deriv | 2023-03-02 | 2023-03-06 | 54,000 | — | $0 | 54,000 | SEC↗ |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | A Award deriv | 2023-03-02 | 2023-03-06 | 94,500 | — | $0 | 94,500 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | A Award | 2023-03-02 | 2023-03-06 | 16,700 | — | $0 | 77,683 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award | 2023-03-02 | 2023-03-06 | 50,000 | — | $0 | 136,655 | SEC↗ |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A Award | 2023-03-02 | 2023-03-06 | 18,000 | — | $0 | 76,372 | SEC↗ |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | A Award | 2023-03-02 | 2023-03-06 | 31,500 | — | $0 | 107,743 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-02-13 | 2023-02-15 | 3,307 | $9.67 | $32.0K | 60,983 | SEC↗ |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S Sale | 2023-02-13 | 2023-02-15 | 4,287 | $9.67 | $41.5K | 76,243 | SEC↗ |
| Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2023-02-13 | 2023-02-15 | 2,790 | $9.67 | $27.0K | 65,559 | SEC↗ |
| Eaton Bruce | EVP, CBO AND CTO | S Sale | 2023-02-07 | 2023-02-09 | 346 | $11.10 | $3.8K | 64,290 | SEC↗ |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S Sale | 2023-01-10 | 2023-01-12 | 1,752 | $8.16 | $14.3K | 80,530 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S Sale | 2022-12-05 | 2022-12-06 | 102 | $10.23 | $1.0K | 64,636 | SEC↗ |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S Sale | 2022-12-05 | 2022-12-06 | 193 | $10.23 | $2.0K | 82,282 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S Sale | 2022-11-08 | 2022-11-09 | 289 | $11.02 | $3.2K | 64,738 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S Sale | 2022-09-06 | 2022-09-08 | 101 | $15.01 | $1.5K | 65,027 | SEC↗ |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S Sale | 2022-09-06 | 2022-09-08 | 192 | $15.01 | $2.9K | 82,475 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S Sale | 2022-08-09 | 2022-08-10 | 293 | $18.60 | $5.4K | 65,128 | SEC↗ |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A Award deriv | 2022-07-18 | 2022-07-20 | 171,602 | — | $0 | 171,602 | SEC↗ |
| Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A Award | 2022-07-18 | 2022-07-20 | 58,372 | — | $0 | 58,372 | SEC↗ |
| Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICE | S Sale | 2022-06-15 | 2022-06-16 | 5,145 | $10.06 | $51.8K | 68,349 | SEC↗ |
| Chatterjee Meeta | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hirsch Andrew | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hopfield Jessica | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Scadden David | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Vaishnaw Akshay | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Reeve Emma | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Connaughton Bernadette | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S Sale | 2022-06-03 | 2022-06-06 | 1,527 | $11.54 | $17.6K | 82,667 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S Sale | 2022-06-03 | 2022-06-06 | 1,123 | $11.54 | $13.0K | 65,421 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award deriv | 2022-06-02 | 2022-06-06 | 950,209 | — | $0 | 950,209 | SEC↗ |
| O'Neill Gilmore Neil | CEO | A Award | 2022-06-02 | 2022-06-06 | 86,655 | — | $0 | 86,655 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S Sale | 2022-05-09 | 2022-05-11 | 297 | $13.11 | $3.9K | 66,544 | SEC↗ |
| MULLEN JAMES C | CEO | A Award deriv | 2022-04-14 | 2022-04-18 | 170,989 | — | $0 | 170,989 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S Sale | 2022-04-01 | 2022-04-04 | 1,258 | $19.64 | $24.7K | 66,841 | SEC↗ |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S Sale | 2022-03-03 | 2022-03-07 | 767 | $17.33 | $13.3K | 84,194 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S Sale | 2022-03-03 | 2022-03-07 | 403 | $17.33 | $7.0K | 68,386 | SEC↗ |
| ROBERTSON MICHELLE | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-02-10 | 2022-02-11 | 157,580 | — | $0 | 157,580 | SEC↗ |
| Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICE | A Award deriv | 2022-02-10 | 2022-02-11 | 93,398 | — | $0 | 93,398 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | A Award deriv | 2022-02-10 | 2022-02-11 | 110,732 | — | $0 | 110,732 | SEC↗ |
| ROBERTSON MICHELLE | CHIEF FINANCIAL OFFICER | A Award | 2022-02-10 | 2022-02-11 | 53,499 | — | $0 | 84,961 | SEC↗ |
| Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICE | A Award | 2022-02-10 | 2022-02-11 | 31,709 | — | $0 | 73,494 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | A Award | 2022-02-10 | 2022-02-11 | 37,593 | — | $0 | 68,789 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S Sale | 2022-02-08 | 2022-02-10 | 302 | $17.63 | $5.3K | 31,196 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | S Sale | 2022-01-11 | 2022-01-13 | 1,744 | $25.70 | $44.8K | 31,462 | SEC↗ |
| MULLEN JAMES C | CEO | S Sale | 2022-01-03 | 2022-01-04 | 18,252 | $26.95 | $491.9K | 75,898 | SEC↗ |
| MULLEN JAMES C | CEO | A Award | 2021-12-22 | 2021-12-23 | 36,477 | — | $0 | 94,150 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | A Award | 2021-12-22 | 2021-12-23 | 4,471 | — | $0 | 33,206 | SEC↗ |
| Shearman Mark S | EVP, Chief Scientific Office | A Award | 2021-12-22 | 2021-12-23 | 9,084 | — | $0 | 41,785 | SEC↗ |
| Michaels Lisa Anne | EVP/Chief Medical Officer | A Award | 2021-12-22 | 2021-12-23 | 4,243 | — | $0 | 22,675 | SEC↗ |
| Eaton Bruce | EVP, Chief Business Officer | A Award | 2021-12-22 | 2021-12-23 | 3,472 | — | $0 | 31,498 | SEC↗ |
| Michaels Lisa Anne | EVP/Chief Medical Officer | S Sale | 2021-11-12 | 2021-11-15 | 1,568 | $38.33 | $60.1K | 18,432 | SEC↗ |
| Eaton Bruce | EVP, Chief Business Officer | S Sale | 2021-11-09 | 2021-11-10 | 287 | $40.61 | $11.7K | 28,026 | SEC↗ |
| Connaughton Bernadette | Director | A Award deriv | 2021-10-26 | 2021-10-28 | 24,732 | — | $0 | 24,732 | SEC↗ |
| MULLEN JAMES C | CEO | S Sale | 2021-10-18 | 2021-10-20 | 13,805 | $38.03 | $525.0K | 57,673 | SEC↗ |
| MULLEN JAMES C | CEO | A Award | 2021-09-30 | 2021-10-04 | 36,478 | — | $0 | 71,478 | SEC↗ |
| Reeve Emma | Director | A Award deriv | 2021-09-03 | 2021-09-08 | 13,736 | — | $0 | 13,736 | SEC↗ |
| Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S Sale | 2021-08-09 | 2022-04-04 | 287 | $57.17 | $16.4K | 68,099 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | M Exercise deriv | 2021-08-09 | 2021-08-10 | 2,500 | — | $0 | 115,000 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | S Sale | 2021-08-09 | 2021-08-10 | 2,500 | $60.00 | $150.0K | 28,735 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | M Exercise | 2021-08-09 | 2021-08-10 | 2,500 | $30.65 | $76.6K | 31,235 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | M Exercise deriv | 2021-06-28 | 2021-06-30 | 2,500 | — | $0 | 117,500 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | S Sale | 2021-06-28 | 2021-06-30 | 2,500 | $50.00 | $125.0K | 28,735 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | M Exercise | 2021-06-28 | 2021-06-30 | 2,500 | $30.65 | $76.6K | 31,235 | SEC↗ |
| Shearman Mark S | EVP, Chief Scientific Office | A Award deriv | 2021-06-14 | 2021-06-16 | 52,718 | — | $0 | 52,718 | SEC↗ |
| MULLEN JAMES C | CEO | A Award deriv | 2021-06-14 | 2021-06-16 | 170,989 | — | $0 | 170,989 | SEC↗ |
| Shearman Mark S | EVP, Chief Scientific Office | A Award | 2021-06-14 | 2021-06-16 | 32,701 | — | $0 | 32,701 | SEC↗ |
| Hopfield Jessica | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Hirsch Andrew | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Chatterjee Meeta | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Scadden David | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Vaishnaw Akshay | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Hopfield Jessica | Director | P Buy | 2021-03-03 | 2021-03-05 | 5,800 | $45.51 | $264.0K | 22,700 | SEC↗ |
| MULLEN JAMES C | CEO | A Award deriv | 2021-03-02 | 2021-03-04 | 196,637 | — | $0 | 196,637 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | A Award deriv | 2021-03-02 | 2021-03-04 | 32,197 | — | $0 | 32,197 | SEC↗ |
| MULLEN JAMES C | CEO | P Buy | 2021-03-02 | 2021-03-04 | 25,000 | $46.27 | $1.16M | 35,000 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | A Award | 2021-03-02 | 2021-03-04 | 10,303 | — | $0 | 28,735 | SEC↗ |
| Collins Cynthia | CEO | S Sale | 2021-02-09 | 2021-02-10 | 1,262 | $66.65 | $84.1K | 43,760 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | S Sale | 2021-01-12 | 2021-01-13 | 1,568 | $78.27 | $122.7K | 18,432 | SEC↗ |
| Chatterjee Meeta | Director | A Award deriv | 2020-12-17 | 2020-12-18 | 23,076 | — | $0 | 23,076 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | M Exercise deriv | 2020-12-15 | 2020-12-17 | 10,000 | — | $0 | 145,000 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-12-15 | 2020-12-17 | 200 | $64.39 | $12.9K | 24,907 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-12-15 | 2020-12-17 | 4,024 | $63.84 | $256.9K | 25,107 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | M Exercise | 2020-12-15 | 2020-12-17 | 10,000 | $16.51 | $165.1K | 34,907 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-12-15 | 2020-12-17 | 5,776 | $62.74 | $362.4K | 29,131 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | M Exercise deriv | 2020-12-09 | 2020-12-11 | 10,000 | — | $0 | 155,000 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-12-09 | 2020-12-11 | 10,000 | $45.00 | $450.0K | 24,907 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | M Exercise | 2020-12-09 | 2020-12-11 | 10,000 | $16.51 | $165.1K | 34,907 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | M Exercise deriv | 2020-12-07 | 2020-12-08 | 20,000 | — | $0 | 165,000 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-12-07 | 2020-12-08 | 20,000 | $40.02 | $800.4K | 24,907 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | M Exercise | 2020-12-07 | 2020-12-08 | 20,000 | $16.51 | $330.2K | 44,907 | SEC↗ |
| Michaels Lisa Anne | EVP/Chief Medical Officer | A Award deriv | 2020-11-09 | 2020-11-10 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-11-09 | 2020-11-10 | 228 | $31.21 | $7.1K | 24,907 | SEC↗ |
| Michaels Lisa Anne | EVP/Chief Medical Officer | A Award | 2020-11-09 | 2020-11-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-10-15 | 2020-10-16 | 3,000 | $31.39 | $94.2K | 25,135 | SEC↗ |
| Collins Cynthia | CEO | S Sale | 2020-08-20 | 2020-08-21 | 1,976 | $36.66 | $72.4K | 45,022 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | M Exercise deriv | 2020-08-17 | 2020-08-19 | 10,000 | — | $0 | 185,000 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | M Exercise | 2020-08-17 | 2020-08-19 | 10,000 | $16.51 | $165.1K | 38,135 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-08-17 | 2020-08-19 | 10,000 | $35.29 | $352.9K | 28,135 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-08-07 | 2020-08-10 | 238 | $34.99 | $8.3K | 28,135 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | M Exercise deriv | 2020-08-06 | 2020-08-10 | 10,000 | — | $0 | 195,000 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-08-06 | 2020-08-10 | 10,000 | $37.47 | $374.7K | 28,373 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | M Exercise | 2020-08-06 | 2020-08-10 | 10,000 | $16.51 | $165.1K | 38,373 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-07-15 | 2020-07-17 | 3,000 | $32.22 | $96.7K | 28,373 | SEC↗ |
| Scadden David | Director | A Award deriv | 2020-06-10 | 2020-06-12 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Vaishnaw Akshay | Director | A Award deriv | 2020-06-10 | 2020-06-12 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Hirsch Andrew | Director | A Award deriv | 2020-06-10 | 2020-06-12 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Hopfield Jessica | Director | A Award deriv | 2020-06-10 | 2020-06-12 | 11,538 | — | $0 | 11,538 | SEC↗ |
| MULLEN JAMES C | Director | A Award deriv | 2020-06-10 | 2020-06-12 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Albright Charles | EVP/Chief Scientific Officer | S Sale | 2020-05-06 | 2020-05-08 | 151 | $25.28 | $3.8K | 31,373 | SEC↗ |
| Albright Charles | Chief Scientific Officer | S Sale | 2020-02-07 | 2020-02-10 | 622 | $26.95 | $16.8K | 31,524 | SEC↗ |
| Collins Cynthia | CEO | A Award deriv | 2020-02-06 | 2020-02-10 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Albright Charles | Chief Scientific Officer | A Award deriv | 2020-02-06 | 2020-02-10 | 69,556 | — | $0 | 69,556 | SEC↗ |
| Collins Cynthia | CEO | A Award | 2020-02-06 | 2020-02-10 | 15,625 | — | $0 | 46,998 | SEC↗ |
| Albright Charles | Chief Scientific Officer | A Award | 2020-02-06 | 2020-02-10 | 11,593 | — | $0 | 32,146 | SEC↗ |
| Albright Charles | Chief Scientific Officer | S Sale | 2020-02-03 | 2020-02-04 | 5,549 | $26.54 | $147.3K | 20,553 | SEC↗ |
| Albright Charles | Chief Scientific Officer | M Exercise deriv | 2020-01-31 | 2020-02-04 | 17,977 | — | $0 | 0 | SEC↗ |
| Albright Charles | Chief Scientific Officer | M Exercise | 2020-01-31 | 2020-02-04 | 17,977 | — | $0 | 26,102 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | A Award deriv | 2020-01-09 | 2020-01-10 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ROBERTSON MICHELLE | Chief Financial Officer | A Award | 2020-01-09 | 2020-01-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Abrams Judith R | Chief Medical Officer | A Award deriv | 2019-10-28 | 2019-10-30 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Abrams Judith R | Chief Medical Officer | A Award | 2019-10-28 | 2019-10-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Collins Cynthia | CEO | A Award deriv | 2019-09-11 | 2019-09-13 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Collins Cynthia | CEO | A Award deriv | 2019-09-11 | 2019-09-13 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Collins Cynthia | CEO | A Award | 2019-09-11 | 2019-09-13 | 20,000 | — | $0 | 31,373 | SEC↗ |
| Collins Cynthia | CEO | S Sale | 2019-08-19 | 2019-08-21 | 5,193 | $25.83 | $134.1K | 11,373 | SEC↗ |
| Collins Cynthia | CEO | A Award | 2019-08-19 | 2019-08-21 | 8,283 | — | $0 | 16,566 | SEC↗ |
| Collins Cynthia | CEO | A Award | 2019-08-06 | 2019-08-07 | 8,283 | — | $0 | 16,566 | SEC↗ |
| Collins Cynthia | Interim CEO | A Award deriv | 2019-06-12 | 2019-06-14 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Vaishnaw Akshay | Director | A Award deriv | 2019-06-12 | 2019-06-14 | 11,538 | — | $0 | 11,538 | SEC↗ |
| MULLEN JAMES C | Director | A Award deriv | 2019-06-12 | 2019-06-14 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Hopfield Jessica | Director | A Award deriv | 2019-06-12 | 2019-06-14 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Hirsch Andrew | Director | A Award deriv | 2019-06-12 | 2019-06-14 | 11,538 | — | $0 | 11,538 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise deriv | 2019-03-18 | 2019-03-20 | 3,000 | — | $0 | 73,307 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | S Sale | 2019-03-18 | 2019-03-20 | 3,000 | $24.50 | $73.5K | 0 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise | 2019-03-18 | 2019-03-20 | 3,000 | $0.65 | $1.9K | 3,000 | SEC↗ |
| Hopfield Jessica | Director | P Buy | 2019-03-05 | 2019-03-07 | 10,200 | $23.94 | $244.2K | 16,900 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise deriv | 2019-02-20 | 2019-02-22 | 3,000 | — | $0 | 76,307 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise | 2019-02-20 | 2019-02-22 | 3,000 | $0.65 | $1.9K | 3,000 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | S Sale | 2019-02-20 | 2019-02-22 | 3,000 | $20.42 | $61.3K | 0 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | A Award deriv | 2019-02-06 | 2019-02-08 | 48,750 | — | $0 | 48,750 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | A Award deriv | 2019-02-06 | 2019-02-08 | 8,125 | — | $0 | 8,125 | SEC↗ |
| Albright Charles | Chief Scientific Officer | A Award deriv | 2019-02-06 | 2019-02-08 | 8,125 | — | $0 | 8,125 | SEC↗ |
| Albright Charles | Chief Scientific Officer | A Award deriv | 2019-02-06 | 2019-02-08 | 48,750 | — | $0 | 48,750 | SEC↗ |
| Scadden David | Director | A Award deriv | 2019-02-05 | 2019-02-07 | 23,076 | — | $0 | 23,076 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | M Exercise deriv | 2019-02-04 | 2019-02-06 | 6,895 | — | $0 | 9,618 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | S Sale | 2019-02-04 | 2019-02-06 | 6,895 | $21.39 | $147.5K | 0 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | M Exercise | 2019-02-04 | 2019-02-06 | 6,895 | $6.48 | $44.7K | 6,895 | SEC↗ |
| Albright Charles | Chief Scientific Officer | A Award deriv | 2019-01-31 | 2019-02-04 | 17,977 | — | $0 | 17,977 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | A Award deriv | 2019-01-31 | 2019-02-04 | 16,722 | — | $0 | 16,722 | SEC↗ |
| Collins Cynthia | Director | A Award deriv | 2019-01-31 | 2019-02-04 | 8,283 | — | $0 | 8,283 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise deriv | 2019-01-18 | 2019-01-18 | 4,000 | — | $0 | 52,897 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise | 2019-01-18 | 2019-01-18 | 4,000 | $11.21 | $44.8K | 4,000 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | S Sale | 2019-01-18 | 2019-01-18 | 4,000 | $26.50 | $106.0K | 0 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise deriv | 2019-01-17 | 2019-01-18 | 3,000 | — | $0 | 79,307 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | S Sale | 2019-01-17 | 2019-01-18 | 3,000 | $26.18 | $78.5K | 0 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise | 2019-01-17 | 2019-01-18 | 3,000 | $0.65 | $1.9K | 3,000 | SEC↗ |
| Bosley Katrine | President and CEO | S Sale | 2019-01-08 | 2019-01-10 | 12,000 | $25.27 | $303.2K | 1,204,966 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | M Exercise deriv | 2019-01-04 | 2019-01-08 | 7,000 | — | $0 | 16,513 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | S Sale | 2019-01-04 | 2019-01-08 | 7,000 | $22.48 | $157.4K | 0 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | M Exercise | 2019-01-04 | 2019-01-08 | 7,000 | $6.48 | $45.4K | 7,000 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise deriv | 2018-12-18 | 2018-12-19 | 4,000 | — | $0 | 56,897 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise | 2018-12-18 | 2018-12-19 | 4,000 | $11.21 | $44.8K | 4,000 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | S Sale | 2018-12-18 | 2018-12-19 | 4,000 | $27.41 | $109.6K | 0 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 3,000 | — | $0 | 82,307 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | S Sale | 2018-12-17 | 2018-12-19 | 2,300 | $27.75 | $63.8K | 700 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise | 2018-12-17 | 2018-12-19 | 3,000 | $0.65 | $1.9K | 3,000 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | S Sale | 2018-12-17 | 2018-12-19 | 700 | $28.34 | $19.8K | 0 | SEC↗ |
| Collins Cynthia | Director | A Award deriv | 2018-12-06 | 2018-12-10 | 23,076 | — | $0 | 23,076 | SEC↗ |
| Bosley Katrine | President and CEO | S Sale | 2018-12-03 | 2018-12-06 | 100 | $32.39 | $3.2K | 1,216,966 | SEC↗ |
| Bosley Katrine | President and CEO | S Sale | 2018-12-03 | 2018-12-06 | 11,900 | $31.92 | $379.8K | 1,217,066 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | M Exercise deriv | 2018-11-23 | 2019-01-08 | 5,284 | — | $0 | 119,143 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | M Exercise | 2018-11-23 | 2019-01-08 | 5,284 | $3.23 | $17.1K | 5,284 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | M Exercise deriv | 2018-11-23 | 2018-11-27 | 5,284 | — | $0 | 12,229 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | S Sale | 2018-11-23 | 2018-11-27 | 100 | $28.61 | $2.9K | 0 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | S Sale | 2018-11-23 | 2018-11-27 | 5,184 | $28.14 | $145.9K | 100 | SEC↗ |
| Hack Andrew A. F. | Chief Financial Officer | M Exercise | 2018-11-23 | 2018-11-27 | 5,284 | $6.48 | $34.2K | 5,284 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise deriv | 2018-11-20 | 2018-11-21 | 4,000 | — | $0 | 60,897 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise | 2018-11-20 | 2018-11-21 | 4,000 | $11.21 | $44.8K | 4,000 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | S Sale | 2018-11-20 | 2018-11-21 | 4,000 | $26.50 | $106.0K | 0 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise deriv | 2018-11-19 | 2018-11-21 | 3,000 | — | $0 | 85,307 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | S Sale | 2018-11-19 | 2018-11-21 | 300 | $28.85 | $8.7K | 0 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise | 2018-11-19 | 2018-11-21 | 300 | $0.65 | $195 | 300 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | S Sale | 2018-11-19 | 2018-11-21 | 2,700 | $28.12 | $75.9K | 0 | SEC↗ |
| Myer Vickesh | Chief Technology Officer | M Exercise | 2018-11-19 | 2018-11-21 | 2,700 | $0.65 | $1.8K | 2,700 | SEC↗ |